-
Loading metrics
Analytical validation and sequencing coverage studies suggest that performance of a liquid biopsy assay is tumor agnostic (DNA-is-DNA)
-
Wei Meng ,
Roles Formal analysis, Writing – original draft, Writing – review & editing
* E-mail: wmeng@foundationmedicine.com
Affiliation Foundation Medicine, Inc., Boston, Massachusetts, United States of America
⨯ - Russell Petry,
- Norberto Pantoja Galicia,
- Allison van den Hout,
- Jessie Yu,
- Siliang Gong,
- Dhara Shah,
- Daokun Sun,
- Cui Guo,
- Shannon Bailey,
- Daniela Munafo,
- Ryan Woodhouse,
- Elizabeth Mansfield,
- Varun Pattani,
- Steven Perrault,
- Jun Zhou,
- Christine Vietz,
- Meijuan Li,
- [ ... ],
- Richard S.P. Huang
- [ view all ]
- [ view less ]
https://orcid.org/0009-0002-2300-3960
Analytical validation and sequencing coverage studies suggest that performance of a liquid biopsy assay is tumor agnostic (DNA-is-DNA)
- Wei Meng,
- Russell Petry,
- Norberto Pantoja Galicia,
- Allison van den Hout,
- Jessie Yu,
- Siliang Gong,
- Dhara Shah,
- Daokun Sun,
- Cui Guo,
- Shannon Bailey
x
- Published: August 1, 2025
- https://doi.org/10.1371/journal.pone.0329392